During the past decade, Chest Hospitalof Xinjiang Uygur Autonomous Region of PRC conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Chest Hospitalof Xinjiang Uygur Autonomous Region of PRC" are "Multidrug Resistant Tuberculosis" (4 trials). Many other conditions were trialed in "Chest Hospitalof Xinjiang Uygur Autonomous Region of PRC" in a lesser frequency.

Most popular intervention types in "Chest Hospitalof Xinjiang Uygur Autonomous Region of PRC" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Bedaquiline" (1 trials), "Clofazimine" (1 trials), "Cycloserine" (1 trials), "Linezolid" (1 trials) and "NGS-guided regimen: Regimen A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chest Hospitalof Xinjiang Uygur Autonomous Region of PRC" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Chest Hospitalof Xinjiang Uygur Autonomous Region of PRC". 1 are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Chest Hospitalof Xinjiang Uygur Autonomous Region of PRC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chest Hospitalof Xinjiang Uygur Autonomous Region of PRC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".